Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Chronic Renal Failure

Free Subscription Articles published in Am J Nephrol Retrieve available abstracts of 112 articles: HTML format

Single Articles

May 2024
1. GARDEZI AI, Yuan Z, Aziz F, Parajuli S, et al
   Effect of End-Stage Renal Disease Prospective Payment System on Utilization of Peritoneal Dialysis in Patients with Kidney Allograft Failure.
   Am J Nephrol. 2024 May 16. doi: 10.1159/000539062.
   PubMed     Abstract available
   
   
   
2. VAN REETH O, Caliment A, de la Fuente Garcia I, Niel O, et al
   Safety profile and effectiveness of dapagliflozin in pediatric patients with chronic kidney disease.
   Am J Nephrol. 2024 May 11. doi: 10.1159/000539300.
   PubMed     Abstract available
   
   
   April 2024
3. ALSULAMI MM, Al-Otaibi NE, Alshahrani WA, Altheaby A, et al
   The predictors and risk factors of two-year rejection in renal transplant patients: A multicenter case-control study.
   Am J Nephrol. 2024 Apr 26. doi: 10.1159/000538963.
   PubMed     Abstract available
   
   
   March 2024
4. LE D, Crews DC, Grams ME, Coresh J, et al
   Association of Sevelamer Initiation with Gastrointestinal Bleeding Hospitalization in Individuals Requiring Hemodialysis.
   Am J Nephrol. 2024 Mar 29. doi: 10.1159/000538253.
   PubMed     Abstract available
   
   
   
5. BOBOT M, Hak JF, Casolla B, Dehondt JD, et al
   Acute and chronic kidney dysfunction and prognosis following thrombectomy for ischemic stroke.
   Am J Nephrol. 2024 Mar 18. doi: 10.1159/000536493.
   PubMed     Abstract available
   
   
   
6. TSAI YL, Chung MH, Lin NC, Chen CY, et al
   The risk factors and clinical outcomes in hepatitis B seropositive and seronegative renal transplant patients.
   Am J Nephrol. 2024 Mar 18. doi: 10.1159/000538231.
   PubMed     Abstract available
   
   
   February 2024
7. STAVAS J, Silva AL, Wooldridge TD, Aqeel A, et al
   Rilparencel (Renal Autologous Cell Therapy-REACT(R)) for Chronic Kidney Disease and Type 1 and 2 Diabetes: Phase 2 Trial Design Evaluating Bilateral Kidney Dosing and Re-Dosing Triggers.
   Am J Nephrol. 2024 Feb 29. doi: 10.1159/000537942.
   PubMed     Abstract available
   
   
   
8. MAKAWI AT, Tawfik YMK, Dixon DL, McMahon GM, et al
   Expanding the Impact of SGLT2 Inhibitors in Chronic Kidney Disease.
   Am J Nephrol. 2024 Feb 28:1-4. doi: 10.1159/000536540.
   PubMed    
   
   
   
9. CROUCH E, Yell N, Herbert L, Browne T, et al
   Availability and quality of dialysis care in rural versus urban U.S. counties.
   Am J Nephrol. 2024 Feb 11. doi: 10.1159/000537763.
   PubMed     Abstract available
   
   
   January 2024
10. FISHBANE S, Clegg DJ, Lerma EV, Rastogi A, et al
    Difelikefalin in Black/African American Hemodialysis Patients with Moderate-to-Severe Pruritus: Post-hoc Analysis of KALM-1 and KALM-2.
    Am J Nephrol. 2024 Jan 22. doi: 10.1159/000534227.
    PubMed     Abstract available
    
    
    
11. PEREZ-GOMEZ A, Fernandez L, Schanstra JP, Klein J, et al
    Klotho and Mortality in Chronic Kidney Disease: Actor, Risk Factor, or Predictor?
    Am J Nephrol. 2024 Jan 10:1-3. doi: 10.1159/000535752.
    PubMed    
    
    
    
12. ZAHR RS, Saraf SL
    Sickle Cell Disease and CKD: An Update.
    Am J Nephrol. 2024;55:56-71.
    PubMed     Abstract available
    
    
    December 2023
13. HAN S, Zhang X, Wang X, Wang Y, et al
    Association Between Serum Klotho and All-Cause Mortality in Chronic Kidney Disease: Evidence From a Prospective Cohort Study.
    Am J Nephrol. 2023 Dec 16. doi: 10.1159/000535808.
    PubMed     Abstract available
    
    
    
14. MEDAURA JA, Zhou M, Ficociello LH, Anger MS, et al
    Serum phosphorus management with sucroferric oxyhydroxide as a first-line phosphate binder within the first year of hemodialysis.
    Am J Nephrol. 2023 Dec 13. doi: 10.1159/000535754.
    PubMed     Abstract available
    
    
    
15. NOPPAKUN K, Nochaiwong S, Tantraworasin A, Khorana J, et al
    Mortality rates and a clinical predictive model for the elderly on maintenance hemodialysis: A large observational cohort study of 17,354 Asian patients.
    Am J Nephrol. 2023 Dec 8. doi: 10.1159/000535669.
    PubMed     Abstract available
    
    
    November 2023
16. ELENJICKAL EJ, Travlos CK, Marques P, Mavrakanas TA, et al
    Anticoagulation in Patients with Chronic Kidney Disease.
    Am J Nephrol. 2023 Nov 30. doi: 10.1159/000535546.
    PubMed     Abstract available
    
    
    
17. GAO LQ, Xue CC, Cui J, Xu J, et al
    Diabetic Retinopathy and Chronic Kidney Disease: Associations and Comorbidities in a Large Diabetic Population: The Tongren Health Care Study.
    Am J Nephrol. 2023 Nov 10. doi: 10.1159/000535059.
    PubMed     Abstract available
    
    
    
18. ONG SW, Kitchlu A, Cherney DZI, Leung K, et al
    Virtual Pharmacy: An Integrated Collaborative Redesign Targeting Medication-related Problems in Patients with Chronic Kidney Disease.
    Am J Nephrol. 2023 Nov 8. doi: 10.1159/000535094.
    PubMed     Abstract available
    
    
    
19. NAKASHIMA A, Miyawaki Y, Komaba H, Kurita N, et al
    Proton pump inhibitors and hyporesponsiveness to erythropoiesis stimulating agents in hemodialysis patients: results from the Japan Dialysis Outcomes and Practice Patterns Study.
    Am J Nephrol. 2023 Nov 7. doi: 10.1159/000534701.
    PubMed     Abstract available
    
    
    October 2023
20. WANG Y, Chen X, Zhu H, Guo Z, et al
    Efficacy and safety of ferric citrate on hyperphosphatemia among Chinese patients with chronic kidney disease undergoing hemodialysis: a phase III multicenter randomized open-label active-drug controlled study.
    Am J Nephrol. 2023 Oct 9. doi: 10.1159/000534484.
    PubMed     Abstract available
    
    
    
21. MASE K, Yamagata K, Yamamoto H, Tsuruya K, et al
    Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in patients with non-dialysis-dependent chronic kidney disease (RADIANCE-CKD Study).
    Am J Nephrol. 2023 Oct 4. doi: 10.1159/000534438.
    PubMed     Abstract available
    
    
    
22. YUAN CY, Gao YC, Lin Y, Liu L, et al
    Effects of Mineralocorticoid Receptor Antagonists for Chronic Kidney Disease: A Systemic Review and Meta-Analysis.
    Am J Nephrol. 2023 Oct 4. doi: 10.1159/000534366.
    PubMed     Abstract available
    
    
    
23. FAITATZIDOU D, Karagiannidis AG, Theodorakopoulou MP, Xanthopoulos A, et al
    Autonomic nervous system dysfunction in peritoneal dialysis patients: an underrecognized cardiovascular risk factor?
    Am J Nephrol. 2023 Oct 3. doi: 10.1159/000534318.
    PubMed     Abstract available
    
    
    
24. TSAI HL, Lin TC, Lin NC, Yang HH, et al
    Risk factors for fractures in renal transplantation: a population-based cohort study.
    Am J Nephrol. 2023 Oct 2. doi: 10.1159/000533125.
    PubMed     Abstract available
    
    
    September 2023
25. CHINNADURAI R, Rengarajan S, Budden JJ, Quinn CM, et al
    Maintaining renin-angiotensin-aldosterone system inhibitor treatment with patiromer in hyperkalaemic chronic kidney disease patients: comparison of a propensity-matched real-world population with AMETHYST-DN.
    Am J Nephrol. 2023 Sep 19. doi: 10.1159/000533753.
    PubMed     Abstract available
    
    
    
26. YOU AS, Norris KC, Kataoka-Yahiro M, Davis J, et al
    Racial Disparities in End-Stage Kidney Disease Outcomes Among Asians and Native Hawaiians and Other Pacific Islanders Across Geographic Residence.
    Am J Nephrol. 2023 Sep 19. doi: 10.1159/000534052.
    PubMed     Abstract available
    
    
    
27. KOYA D, Anker SD, Ruilope LM, Rossing P, et al
    Cardiorenal Outcomes with Finerenone in Asian Patients with Chronic Kidney Disease and Type 2 Diabetes: A FIDELIO-DKD post hoc Analysis.
    Am J Nephrol. 2023 Sep 14:1-9. doi: 10.1159/000532102.
    PubMed     Abstract available
    
    
    
28. MENDONCA LCF, Vieira MB, Sergio Neves J, Castro Chaves P, et al
    A 4-variable model to predict cardio-kidney events and mortality in chronic kidney disease: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Am J Nephrol. 2023 Sep 6. doi: 10.1159/000533223.
    PubMed     Abstract available
    
    
    August 2023
29. LAI SW
    Comment on Kang et al.'s "Comparison between the Effects of Allopurinol and Febuxostat on the Survival of Patients on Maintenance Hemodialysis".
    Am J Nephrol. 2023 Aug 17:1-2. doi: 10.1159/000533172.
    PubMed    
    
    
    
30. CHEN H, Tang H, Huang J, Luo N, et al
    Life's Essential 8 and Mortality in US Adults with Chronic Kidney Disease.
    Am J Nephrol. 2023 Aug 17. doi: 10.1159/000533257.
    PubMed     Abstract available
    
    
    
31. HU H, Wu C, Kwok JYY, Ho MH, et al
    Effects of different exercises on physical function, dialysis adequacy, and health-related quality of life in maintenance hemodialysis patients: A systematic review and network meta-analysis.
    Am J Nephrol. 2023 Aug 3. doi: 10.1159/000532109.
    PubMed     Abstract available
    
    
    July 2023
32. PATEL S, Trujillo Rivera EA, Raman VK, Faselis C, et al
    Impact of the COVID-19 pandemic on the provision of dialysis service and mortality in Veterans receiving maintenance hemodialysis in the VA: an interrupted time-series analysis.
    Am J Nephrol. 2023 Jul 31. doi: 10.1159/000532105.
    PubMed     Abstract available
    
    
    June 2023
33. TAGAYA T, Hayashi H, Ogata S, Takahashi K, et al
    Tolvaptan's association with low risk of acute kidney injury in patients with advanced chronic kidney disease and acute decompensated heart failure.
    Am J Nephrol. 2023 Jun 29. doi: 10.1159/000531692.
    PubMed     Abstract available
    
    
    
34. GREENLUND IM, Covassin N, Somers VK
    Hitting the Snooze Button on Chronic Kidney Disease.
    Am J Nephrol. 2023 Jun 21. doi: 10.1159/000531625.
    PubMed     Abstract available
    
    
    
35. IATRIDI F, Theodorakopoulou MP, Karpetas A, Sgouropoulou V, et al
    Association of intradialytic hypertension with future cardiovascular events and mortality in hemodialysis patients: effects of ambulatory blood pressure.
    Am J Nephrol. 2023 Jun 9. doi: 10.1159/000531477.
    PubMed     Abstract available
    
    
    May 2023
36. LI SY, Chen CY, Tsai MT, Lin NC, et al
    Hybrid Method for Peritoneal Dialysis Catheter Insertion: A New Technique for Improved Outcomes and Reduced Costs.
    Am J Nephrol. 2023 May 30. doi: 10.1159/000531162.
    PubMed     Abstract available
    
    
    
37. JIANG B, Tang D, Dai N, Huang C, et al
    Association of self-reported nighttime sleep duration with chronic kidney disease: China Health and Retirement Longitudinal Study.
    Am J Nephrol. 2023 May 30. doi: 10.1159/000531261.
    PubMed     Abstract available
    
    
    
38. LI X, Qureshi AR, Suliman ME, Heimburger O, et al
    Interleukin-6 to albumin ratio as a superior predictor of mortality in end stage kidney disease patients.
    Am J Nephrol. 2023 May 24. doi: 10.1159/000531191.
    PubMed     Abstract available
    
    
    
39. PARK JH, Park HC, Kim DH, Lee YK, et al
    Mortality and risk factors in very elderly patients who start hemodialysis: Korean Renal Data System (KORDS), 2016-2020.
    Am J Nephrol. 2023 May 18:1. doi: 10.1159/000530933.
    PubMed     Abstract available
    
    
    
40. KANG SH, Kim BY, Son EJ, Kim GO, et al
    Comparison between the effects of allopurinol and febuxostat on the survival of patents on maintenance hemodialysis.
    Am J Nephrol. 2023 May 18:1. doi: 10.1159/000530972.
    PubMed     Abstract available
    
    
    
41. GREGG LP, Richardson P, Herrera MA, Akeroyd J, et al
    Documented adverse drug reactions and discontinuation of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease.
    Am J Nephrol. 2023 May 18:1. doi: 10.1159/000530988.
    PubMed     Abstract available
    
    
    
42. TANG C, Wen XY, Lv J, Shi S, et al
    Discontinuation of Renin-Angiotensin System Inhibitors and Clinical Outcomes in Chronic Kidney Disease: A Systemic Review and Meta-Analysis.
    Am J Nephrol. 2023 May 18. doi: 10.1159/000531000.
    PubMed     Abstract available
    
    
    
43. PACKER M
    Mechanistic and Clinical Comparison of the Erythropoietic Effects of SGLT2 Inhibitors and Prolyl Hydroxylase Inhibitors in Patients With Chronic Kidney Disease and Renal Anemia.
    Am J Nephrol. 2023 May 16. doi: 10.1159/000531084.
    PubMed     Abstract available
    
    
    April 2023
44. ORTIZ-SORIANO V, Cama-Olivares A, Liu LJ, Armentrout B, et al
    The optimization of outpatient hemodialysis management for AKI-D patients: A quality improvement study.
    Am J Nephrol. 2023 Apr 8. doi: 10.1159/000530444.
    PubMed     Abstract available
    
    
    
45. PLANTINGA LC, Bender AA, Urbanski M, Hoge C, et al
    Work Experiences of the Interdisciplinary Dialysis Workforce in the United States: A Cross-Sectional Survey.
    Am J Nephrol. 2023 Apr 7. doi: 10.1159/000530553.
    PubMed     Abstract available
    
    
    March 2023
46. ZHAO Q, He Y, Wu N, Wang L, et al
    Non-pharmacological Interventions to Improve Physical Function in Patients with End-stage Renal Disease: A Network Meta-analysis.
    Am J Nephrol. 2023 Mar 30. doi: 10.1159/000530219.
    PubMed     Abstract available
    
    
    
47. SINGH AP, Kalil R, Weir MR
    Role of Sodium-Glucose Cotransporter 2 inhibitors for management of diabetes mellitus in renal transplant recipients; and management strategies for post-transplant hypertension.
    Am J Nephrol. 2023 Mar 24. doi: 10.1159/000530296.
    PubMed     Abstract available
    
    
    
48. MURAKAMI M, Fujii N, Kanda E, Kikuchi K, et al
    Association of four types of vascular access including arterial superficialization with mortality in maintenance hemodialysis patients: a nationwide cohort study in Japan.
    Am J Nephrol. 2023 Mar 14. doi: 10.1159/000529991.
    PubMed     Abstract available
    
    
    
49. RIZK JG, Hsiung JT, Arif Y, Hashemi L, et al
    Triglycerides and Renal Outcomes according to Albuminuria and in Consideration of other Metabolic Syndrome Components in Diabetic US Veterans.
    Am J Nephrol. 2023 Mar 8. doi: 10.1159/000529414.
    PubMed     Abstract available
    
    
    February 2023
50. YANG CW, Lin MC, Shu KH, Tung KT, et al
    Extremely Low Dose of Erythropoiesis-Stimulating Agent May be Associated with Increased Mortality in Hemodialysis Patients.
    Am J Nephrol. 2023 Feb 28. doi: 10.1159/000529806.
    PubMed     Abstract available
    
    
    
51. TUTTLE KR, Wilson JM, Lin Y, Qian HR, et al
    Indicators of Kidney Fibrosis in Patients With Type 2 Diabetes and Chronic Kidney Disease Treated With Dulaglutide.
    Am J Nephrol. 2023 Feb 8. doi: 10.1159/000529374.
    PubMed     Abstract available
    
    
    
52. MACDOUGALL IC, Meadowcroft AM, Blackorby A, Cizman B, et al
    Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D).
    Am J Nephrol. 2023 Feb 3. doi: 10.1159/000528696.
    PubMed     Abstract available
    
    
    January 2023
53. MENDE CW, Samarakoon R, Higgins PJ
    [Mineralocorticoid receptor (MR)-associated mechanisms in diabetic kidney disease and clinical significance of MR antagonists].
    Am J Nephrol. 2023 Jan 20. doi: 10.1159/000528783.
    PubMed     Abstract available
    
    
    
54. CHEN TK, Coca SG, Thiessen-Philbrook HR, Heerspink HJL, et al
    [Urinary Biomarkers of Tubular Health and Risk for Kidney Function Decline or Mortality in Diabetes].
    Am J Nephrol. 2023 Jan 11. doi: 10.1159/000528918.
    PubMed     Abstract available
    
    
    
55. THEOFILIS P, Vordoni A, Kalaitzidis RG
    Epidemiology, Pathophysiology, and Clinical Perspectives of Intradialytic Hypertension.
    Am J Nephrol. 2023;54.
    PubMed     Abstract available
    
    
    
56. PUAPATANAKUL P, Banjongjit A, Kanjanabuch T, Surintrspanont J, et al
    Clinicopathological Characteristics and Impacts on Clinical Outcomes of Thrombotic Microangiopathy Lesions in Patients with Immunoglobulin A Nephropathy in Thailand.
    Am J Nephrol. 2023;54.
    PubMed     Abstract available
    
    
    
57. ZHANG S, Chen X, Hou Z, Xia P, et al
    Renal Outcomes in Older Adults with Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis: A New Prediction Model.
    Am J Nephrol. 2023;54.
    PubMed     Abstract available
    
    
    December 2022
58. NAKAGAWA Y, Komaba H, Wada T, Takahashi H, et al
    Serum sclerostin levels and mortality in hemodialysis patients: An 8-year prospective study.
    Am J Nephrol. 2022 Dec 27. doi: 10.1159/000528795.
    PubMed     Abstract available
    
    
    
59. CHIU V, Gross AL, Chu NM, Segev D, et al
    Domains for a Comprehensive Geriatric Assessment of Older Adults with Chronic Kidney Disease: Results from the CRIC Study.
    Am J Nephrol. 2022 Dec 9. doi: 10.1159/000528602.
    PubMed     Abstract available
    
    
    
60. FAITATZIDOU D, Dipla K, Theodorakopoulou MP, Koutlas A, et al
    Hemodialysis effects on autonomic function: results of linear and non-linear analysis of heart-rate-variability at rest and in response to physical and mental stress tests.
    Am J Nephrol. 2022 Dec 8. doi: 10.1159/000528322.
    PubMed     Abstract available
    
    
    
61. LI X, Lindholm B
    Cardiovascular Risk Prediction in Chronic Kidney Disease.
    Am J Nephrol. 2022 Dec 8. doi: 10.1159/000528560.
    PubMed     Abstract available
    
    
    
62. MATHUR VS, Wesson DE, Li E, Tangri N, et al
    Factors Affecting the Decision to Initiate Dialysis: A National Survey of United States Nephrologists.
    Am J Nephrol. 2022 Dec 7. doi: 10.1159/000528167.
    PubMed     Abstract available
    
    
    
63. WESSON DE, Mathur V, Tangri N
    Metabolic Basis and Pathogenesis of Skeletal Muscle Dysfunction as Cause of Frailty in Chronic Kidney Disease.
    Am J Nephrol. 2022 Dec 6:1-13. doi: 10.1159/000526679.
    PubMed     Abstract available
    
    
    
64. TIONG MK, Holt SG, Ford ML, Smith ER, et al
    Serum Calciprotein Monomers and Chronic Kidney Disease Progression.
    Am J Nephrol. 2022 Dec 6:1-10. doi: 10.1159/000526609.
    PubMed     Abstract available
    
    
    November 2022
65. AGARWAL R, Anand S, Eckardt KU, Luo W, et al
    Overall Adverse Event Profile of Vadadustat for the Treatment of Anemia Associated With Chronic Kidney Disease in Phase 3 Trials.
    Am J Nephrol. 2022 Nov 30. doi: 10.1159/000528443.
    PubMed     Abstract available
    
    
    
66. TANGRI N, Mathur V, Reaven N, Funk SE, et al
    Relationship between Metabolic Acidosis and Chronic Kidney Disease Progression across Racial and Ethnic Groups: An Observational, Retrospective Cohort Study.
    Am J Nephrol. 2022 Nov 8:1-11. doi: 10.1159/000527036.
    PubMed     Abstract available
    
    
    
67. SERRANO M, Srivastava A, Buck G, Zhu B, et al
    Dietary Protein and Fiber Affect Gut Microbiome and Treg/Th17 Commitment in Chronic Kidney Disease Mice.
    Am J Nephrol. 2022 Nov 7:1-6. doi: 10.1159/000526957.
    PubMed     Abstract available
    
    
    
68. QU X, Tong X, Hou X, Zhang J, et al
    Trends in Adherence to Recommended Physical Activity and Its Association with Mortality and Disease Progression among US Adults with Chronic Kidney Disease.
    Am J Nephrol. 2022 Nov 7:1-12. doi: 10.1159/000526956.
    PubMed     Abstract available
    
    
    
69. ALLINOVI M, Bergesio F, Cappelli F, Chiappini MG, et al
    Is Hereditary Transthyretin Amyloidosis the Third Leading Cause of Monogenic Chronic Kidney Disease, Only Behind ADPKD and Alport Disease?
    Am J Nephrol. 2022 Nov 7:1-4. doi: 10.1159/000526955.
    PubMed    
    
    
    October 2022
70. BURROWS NR, Koyama AK, Choudhury D, Yu W, et al
    Age-Related Association between Multimorbidity and Mortality in US Veterans with Incident Chronic Kidney Disease.
    Am J Nephrol. 2022 Oct 7:1-11. doi: 10.1159/000526254.
    PubMed     Abstract available
    
    
    September 2022
71. LIU Q, Bai B, Liu F, Chen Y, et al
    Long-Term Trends in Risk Factor Management in Respondents with Chronic Kidney Disease in the USA.
    Am J Nephrol. 2022 Sep 20:1-10. doi: 10.1159/000525733.
    PubMed     Abstract available
    
    
    August 2022
72. XU X, Ma T, Tian X, Li S, et al
    Telemedicine and Clinical Outcomes in Peritoneal Dialysis: A Propensity-Matched Study.
    Am J Nephrol. 2022 Aug 17:1-11. doi: 10.1159/000525917.
    PubMed     Abstract available
    
    
    July 2022
73. EINBINDER Y, Perl J, Nacasch N, Bnaya A, et al
    Humoral Response and SARS-CoV-2 Infection Risk following the Third and Fourth Doses of the BNT162b2 Vaccine in Dialysis Patients.
    Am J Nephrol. 2022 Jul 18:1-5. doi: 10.1159/000525309.
    PubMed     Abstract available
    
    
    June 2022
74. THEOFILIS P, Vordoni A, Kalaitzidis RG
    The Role of Melatonin in Chronic Kidney Disease and Its Associated Risk Factors: A New Tool in Our Arsenal?
    Am J Nephrol. 2022 Jun 29:1-10. doi: 10.1159/000525441.
    PubMed     Abstract available
    
    
    
75. LEGENDRE B, Lobbedez T, Couchoud C, Lassalle M, et al
    Switch from Hemodialysis to Peritoneal Dialysis: Does the Time Spent on Hemodialysis Impact Outcomes in Peritoneal Dialysis?
    Am J Nephrol. 2022 Jun 22:1-10. doi: 10.1159/000524960.
    PubMed     Abstract available
    
    
    
76. VRIST MH, Ostergaard AMH, Langaa SS, Mose FH, et al
    Bone Turnover, Mineralization, and Volume Estimated by 18F-Sodium Fluoride PET/CT and Biomarkers in Chronic Kidney Disease: Mineral and Bone Disorder Compared with Bone Biopsy.
    Am J Nephrol. 2022 Jun 7:1-13. doi: 10.1159/000524961.
    PubMed     Abstract available
    
    
    May 2022
77. WANG K, Qian D, Hu Y, Cheng Y, et al
    Nut Consumption and Effects on Chronic Kidney Disease and Mortality in the United States.
    Am J Nephrol. 2022 May 24:1-10. doi: 10.1159/000524382.
    PubMed     Abstract available
    
    
    
78. BISHOP CW, Strugnell SA, Csomor P, Kaiser E, et al
    Extended-Release Calcifediol Effectively Raises Serum Total 25-Hydroxyvitamin D Even in Overweight Nondialysis Chronic Kidney Disease Patients with Secondary Hyperparathyroidism.
    Am J Nephrol. 2022 May 12:1-9. doi: 10.1159/000524289.
    PubMed     Abstract available
    
    
    April 2022
79. MURRAY AM, Slinin Y, Tupper DE, Pederson SL, et al
    Kidney-Metabolic Factors Associated with Cognitive Impairment in Chronic Kidney Disease: A Pilot Study.
    Am J Nephrol. 2022 Apr 28:1-11. doi: 10.1159/000524166.
    PubMed     Abstract available
    
    
    
80. GOODKIN DA, Zhao J, Cases A, Nangaku M, et al
    Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically Transient.
    Am J Nephrol. 2022 Apr 22:1-10. doi: 10.1159/000523947.
    PubMed     Abstract available
    
    
    
81. AGRAWAL D, Varade D, Shah H, Nazar A, et al
    Desidustat in Anemia due to Non-Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-ND).
    Am J Nephrol. 2022 Apr 22:1-9. doi: 10.1159/000523961.
    PubMed     Abstract available
    
    
    
82. GANG S, Khetan P, Varade D, Chinta VR, et al
    Desidustat in Anemia due to Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-D).
    Am J Nephrol. 2022 Apr 22:1-9. doi: 10.1159/000523949.
    PubMed     Abstract available
    
    
    
83. KIM DH, Park HC, Cho A, Kim J, et al
    Nurse Caseload and Patient Survival in Hemodialysis Units: A Korean Nationwide Cohort Study.
    Am J Nephrol. 2022 Apr 20:1-9. doi: 10.1159/000524110.
    PubMed     Abstract available
    
    
    March 2022
84. GOLLIE JM, Patel SS, Harris-Love MO, Cohen SD, et al
    Fatigability and the Role of Neuromuscular Impairments in Chronic Kidney Disease.
    Am J Nephrol. 2022 Mar 28:1-11. doi: 10.1159/000523714.
    PubMed     Abstract available
    
    
    
85. BLEYER AJ, Westemeyer M, Xie J, Bloom MS, et al
    Genetic Etiologies for Chronic Kidney Disease Revealed through Next-Generation Renal Gene Panel.
    Am J Nephrol. 2022 Mar 24:1-10. doi: 10.1159/000522226.
    PubMed     Abstract available
    
    
    
86. SCHREIER DJ, Rule AD, Kashani KB, Mara KC, et al
    Nephrotoxin Exposure in the 3 Years following Hospital Discharge Predicts Development or Worsening of Chronic Kidney Disease among Acute Kidney Injury Survivors.
    Am J Nephrol. 2022 Mar 16:1-9. doi: 10.1159/000522139.
    PubMed     Abstract available
    
    
    
87. OKUBO A, Doi T, Morii K, Nishizawa Y, et al
    Utility of CHA2DS2-VASc Score to Predict Mid-Term Clinical Outcomes in Hemodialysis Patients.
    Am J Nephrol. 2022 Mar 8:1-7. doi: 10.1159/000522225.
    PubMed     Abstract available
    
    
    February 2022
88. SOOHOO M, Obi Y, Rivara MB, Adams SV, et al
    Comparative Effectiveness of Dialysis Modality on Laboratory Parameters of Mineral Metabolism.
    Am J Nephrol. 2022 Feb 28:1-12. doi: 10.1159/000521508.
    PubMed     Abstract available
    
    
    
89. FUJII N, Hamano T, Hsu JY, Imai E, et al
    A Comparative Study of Serum Phosphate and Related Parameters in Chronic Kidney Disease between the USA and Japan.
    Am J Nephrol. 2022 Feb 28:1-14. doi: 10.1159/000521386.
    PubMed     Abstract available
    
    
    
90. TSAI HC, Ou SM, Wu CC, Huang CC, et al
    Pentraxin 3 Predicts Arteriovenous Fistula Functional Patency Loss and Mortality in Chronic Hemodialysis Patients.
    Am J Nephrol. 2022 Feb 25:1-9. doi: 10.1159/000522049.
    PubMed     Abstract available
    
    
    
91. ZHANG J, Fuhrer T, Ye H, Kwan B, et al
    High-Throughput Metabolomics and Diabetic Kidney Disease Progression: Evidence from the Chronic Renal Insufficiency (CRIC) Study.
    Am J Nephrol. 2022 Feb 23:1-11. doi: 10.1159/000521940.
    PubMed     Abstract available
    
    
    
92. SHASHAR M, Nacasch N, Grupper A, Benchetrit S, et al
    Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients.
    Am J Nephrol. 2022 Feb 16:1-8. doi: 10.1159/000521676.
    PubMed     Abstract available
    
    
    
93. VARETA G, Georgianos PI, Vaios V, Sgouropoulou V, et al
    Epidemiology of Hypertension among Patients on Peritoneal Dialysis Using Standardized Office and Ambulatory Blood Pressure Recordings.
    Am J Nephrol. 2022 Feb 4:1-9. doi: 10.1159/000521861.
    PubMed     Abstract available
    
    
    January 2022
94. BENMIRA AM, Moranne O, Prelipcean C, Pambrun E, et al
    Direct Determination rather than Oscillometric Estimation of Systolic Blood Pressure in Patients with Severe Chronic Kidney Disease.
    Am J Nephrol. 2022 Jan 12:1-9. doi: 10.1159/000520996.
    PubMed     Abstract available
    
    
    
95. BHANDARI SK, Zhou H, Shaw SF, Shi J, et al
    Causes of Death in End-Stage Kidney Disease: Comparison between the United States Renal Data System and a Large Integrated Health Care System.
    Am J Nephrol. 2022 Jan 11:1-9. doi: 10.1159/000520466.
    PubMed     Abstract available
    
    
    
96. ZHU B, Liu WH, Lin Y, Li Q, et al
    Renal Interstitial Inflammation Predicts Nephropathy Progression in IgA Nephropathy: A Two-Center Cohort Study.
    Am J Nephrol. 2022;53:455-469.
    PubMed     Abstract available
    
    
    December 2021
97. DIAMANTIDIS CJ, Zepel L, Wang V, Smith VA, et al
    Disparities in Chronic Kidney Disease Progression by Medicare Advantage Enrollees.
    Am J Nephrol. 2021;52:949-957.
    PubMed     Abstract available
    
    
    
98. YOU HS, Shin SJ, Kim J, Kang HT, et al
    Statin Use and Incidence of Chronic Kidney Disease in Hypercholesterolemia Patients with Normal Renal Function.
    Am J Nephrol. 2021 Dec 3:1-9. doi: 10.1159/000520532.
    PubMed     Abstract available
    
    
    November 2021
99. OTOBE Y, Yamada M, Hiraki K, Onari S, et al
    Physical Exercise Improves Cognitive Function in Older Adults with Stage 3-4 Chronic Kidney Disease: A Randomized Controlled Trial.
    Am J Nephrol. 2021 Nov 30:1-11. doi: 10.1159/000520230.
    PubMed     Abstract available
    
    
    
100. PAIK JM, Zhuo M, York C, Tsacogianis T, et al
     Medication Burden and Prescribing Patterns in Patients on Hemodialysis in the USA, 2013-2017.
     Am J Nephrol. 2021 Nov 23:1-10. doi: 10.1159/000520028.
     PubMed     Abstract available
     
     
     
101. THOMSON BKA, Pilkey NG, Monteith B, Holden RM, et al
     A Scoping Review of Alternative Anticoagulation Strategies for Hemodialysis Patients with a Mechanical Heart Valve.
     Am J Nephrol. 2021;52.
     PubMed     Abstract available
     
     
     
102. WEE HN, Liu JJ, Ching J, Kovalik JP, et al
     The Kynurenine Pathway in Acute Kidney Injury and Chronic Kidney Disease.
     Am J Nephrol. 2021 Nov 9:1-17. doi: 10.1159/000519811.
     PubMed     Abstract available
     
     
     
103. HU S, Wang D, Ma T, Yuan F, et al
     Association between Preoperative Monocyte-to-Lymphocyte Ratio and Late Arteriovenous Fistula Dysfunction in Hemodialysis Patients: A Cohort Study.
     Am J Nephrol. 2021 Nov 8:1-7. doi: 10.1159/000519822.
     PubMed     Abstract available
     
     
     October 2021
104. JELANI QU, Llanos-Chea F, Bogra P, Trejo-Paredes C, et al
     Guideline-Directed Medical Therapy in Patients with Chronic Kidney Disease Undergoing Peripheral Vascular Intervention.
     Am J Nephrol. 2021 Oct 27:1-9. doi: 10.1159/000519484.
     PubMed     Abstract available
     
     
     
105. GOLDBERG A, Garcia-Arroyo F, Sasai F, Rodriguez-Iturbe B, et al
     Mini Review: Reappraisal of Uric Acid in Chronic Kidney Disease.
     Am J Nephrol. 2021 Oct 21:1-8. doi: 10.1159/000519491.
     PubMed     Abstract available
     
     
     
106. SELLIER AB, Seiler-Mussler S, Emrich IE, Bohm M, et al
     FGFR4 and Klotho Polymorphisms Are Not Associated with Cardiovascular Outcomes in Chronic Kidney Disease.
     Am J Nephrol. 2021 Oct 21:1-9. doi: 10.1159/000519274.
     PubMed     Abstract available
     
     
     September 2021
107. EREZ D, Fanadka F, Benchetrit S, Cohen-Hagai K, et al
     The Combined Prognostic Significance of Alkaline Phosphatase and Intracranial Arterial Calcifications in Hemodialysis Patients.
     Am J Nephrol. 2021 Sep 17:1-7. doi: 10.1159/000518399.
     PubMed     Abstract available
     
     
     
108. THEOFILIS P, Vordoni A, Koukoulaki M, Vlachopanos G, et al
     Dyslipidemia in Chronic Kidney Disease: Contemporary Concepts and Future Therapeutic Perspectives.
     Am J Nephrol. 2021 Sep 17:1-9. doi: 10.1159/000518456.
     PubMed     Abstract available
     
     
     
109. CIARDULLO S, Ballabeni C, Trevisan R, Perseghin G, et al
     Metabolic Syndrome, and Not Obesity, Is Associated with Chronic Kidney Disease.
     Am J Nephrol. 2021;52:666-672.
     PubMed     Abstract available
     
     
     January 2021
110. RAJKUMAR T, Wong J, Harvey M, Weidersehn L, et al
     Comparison of Sampling Methods for International Normalized Ratio Monitoring in Haemodialysis Patients (INRHaemo Study).
     Am J Nephrol. 2021;52:17-25.
     PubMed     Abstract available
     
     
     
111. SY J, Hsiung JT, Edgett D, Kalantar-Zadeh K, et al
     Cardiovascular and Bleeding Outcomes with Anticoagulants across Kidney Disease Stages: Analysis of a National US Cohort.
     Am J Nephrol. 2021;52:199-208.
     PubMed     Abstract available
     
     
     
112. SHESHADRI A, Kittiskulnam P, Delgado C, Sudore RL, et al
     Association of Cognitive Function Screening Results with Adherence and Performance in a Pedometer-Based Intervention.
     Am J Nephrol. 2021;52:420-428.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Chronic Renal Failure is free of charge.